The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrison's Principles of Internal Medicine.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-499_2 · Cited by 12,514
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Wilhelm, S. M., Carter, C., Tang, L., Wilkie, D., McNabola, A., Rong, H., Chen, C., Zhang, X., Vincent, P., McHugh, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1443 · Cited by 4,017
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Angiogenesis as a therapeutic target
Ferrara, N., & Kerbel, R. S. (2005) · Nature · doi:10.1038/nature04483 · Cited by 2,653
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Ferrara, N., Hillan, K. J., Gerber, H.-P., & Novotny, W. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1381 · Cited by 2,625
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
Peichev, M., Naiyer, A. J., Pereira, D., Zhu, Z., Lane, W. J., Williams, M., Oz, M. C., Hicklin, D. J., Witte, L., Moore, M. A. S., et al. (2000) · Blood · doi:10.1182/blood.v95.3.952.003k27_952_958 · Cited by 2,277
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
Cines, D. B., Pollak, E. S., Buck, C. A., Loscalzo, J., Zimmerman, G. A., McEver, R. P., Pober, J. S., Wick, T. M., Konkle, B. A., Schwartz, B. S., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3527 · Cited by 2,256
Harrison's Principles of Internal Medicine
Somberg, J. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000179344.69594.75 · Cited by 2,128
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Mendel, D. B., Laird, A., Xin, X., Louie, S. G., Christensen, J. G., Li, G., Schreck, R., Abrams, T. J., Ngai, T. J., Lee, L. B., et al. (2003) · PubMed · Cited by 1,961
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Wilhelm, S., Carter, C., Lynch, M., Lowinger, T., Dumas, J., Smith, R. A., Schwartz, B., Simantov, R., & Kelley, S. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2130 · Cited by 1,829
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Motzer, R. J., Michaelson, M. D., Redman, B. G., Hudes, G. R., Wilding, G., Figlin, R. A., Ginsberg, M. S., Kim, S. T., Baum, C. M., DePrimo, S. E., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2574 · Cited by 1,634
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
Miller, K. D., Chap, L. I., Holmes, F. A., Cobleigh, M. A., Marcom, P. K., Fehrenbacher, L., Dickler, M., Overmoyer, B. A., Reimann, J. D., Sing, A. P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.098 · Cited by 1,306
Sunitinib in Patients With Metastatic Renal Cell Carcinoma
Motzer, R. J., Rini, B. I., Bukowski, R. M., Curti, B. D., George, D. J., Hudes, G. R., Redman, B. G., Margolin, K. A., Merchan, J. R., Wilding, G., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2516 · Cited by 1,230
Faivre, S., Delbaldo, C., Vera, K., Robert, C., Lozahic, S., Lassau, N., Bello, C., Deprimo, S., Brega, N., Massimini, G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2194 · Cited by 1,164
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
Jain, R. K., Duda, D. G., Clark, J. W., & Loeffler, J. S. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0403 · Cited by 1,039
Ratain, M. J., Eisen, T., Stadler, W. M., Flaherty, K. T., Kaye, S. B., Rosner, G. L., Gore, M., Desai, A. A., Patnaik, A., Xiong, H. Q., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6723 · Cited by 1,032
Gordon, M. S., Margolin, K., Talpaz, M., Sledge, G. W., Holmgren, E., Benjamin, R., Stalter, S., Shak, S., & Adelman, D. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.843 · Cited by 913
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R. M., Ferrari, S. M., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) · PubMed · Cited by 845
TARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Kamba, T., Tam, B. Y. Y., Hashizume, H., Haskell, A., Sennino, B., Mancuso, M. R., Norberg, S. M., O'Brien, S. M., Davis, R. B., Gowen, L. C., et al. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00133.2005 · Cited by 775
Möhle, R., Green, D., Moore, M. A. S., Nachman, R. L., & Rafii, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.663 · Cited by 713
Fundamental Concepts of the Angiogenic Process
Folkman, J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479465 · Cited by 666
Abrams, T. J., Lee, L. B., Murray, L. J., Pryer, N., & Cherrington, J. M. (2003) · PubMed · Cited by 636
Apoptotic Vascular Endothelial Cells Become Procoagulant
Bombeli, T., Karsan, A., Tait, J. F., & Harlan, J. M. (1997) · Blood · doi:10.1182/blood.v89.7.2429 · Cited by 622
Banks, R., Forbes, M., Kinsey, S., Stanley, A., Ingham, E., Walters, C., & Selby, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.158 · Cited by 599
Cutaneous side-effects of kinase inhibitors and blocking antibodies
Robert, C., Soria, J.-C., Spatz, A., Le Cesne, A., Malka, D., Pautier, P., Wechsler, J., Lhomme, C., Escudier, B., Boige, V., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70243-6 · Cited by 554
Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A., & Kalluri, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300012200 · Cited by 538
Scappaticci, F. A., Fehrenbacher, L., Cartwright, T., Hainsworth, J. D., Heim, W., Berlin, J., Kabbinavar, F., Novotny, W., Sarkar, S., & Hurwitz, H. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20301 · Cited by 537
Folkman, J., & Kalluri, R. (2004) · Nature · doi:10.1038/427787a · Cited by 519
Fiedler, W., Serve, H., Döhner, H., Schwittay, M., Ottmann, O. G., O'Farrell, A.-M., Bello, C. L., Allred, R., Manning, W. C., Cherrington, J. M., et al. (2005) · Blood · doi:10.1182/blood-2004-05-1846 · Cited by 490
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
COBLEIGH, M. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.013 · Cited by 488
BAY 43-9006 Inhibition of Oncogenic RET Mutants
Carlomagno, F., Anaganti, S., Guida, T., Salvatore, G., Troncone, G., Wilhelm, S. M., & Santoro, M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj069 · Cited by 476
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Willett, C. G., Boucher, Y., Duda, D. G., di Tomaso, E., Munn, L. L., Tong, R. T., Kozin, S. V., Petit, L., Jain, R. K., Chung, D. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.5635 · Cited by 420
Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors
Desai, J., Yassa, L., Marqusee, E., George, S., Frates, M. C., Chen, M. H., Morgan, J. A., Dychter, S. S., Larsen, P. R., Demetri, G. D., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-9-200611070-00008 · Cited by 405
Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis
Kwiatkowski, D. J. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.5.446 · Cited by 387
Flow Effects on Coagulation and Thrombosis
Hathcock, J. J. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000229658.76797.30 · Cited by 387
Platelet: transporter of vascular endothelial growth factor.
Verheul, H. M. W., Hoekman, K., Bakker, S., Eekman, C., Folman, C. C., Broxterman, H. J., & Pinedo, H. M. (1997) · PubMed · Cited by 378
Self-citationBaffert, F., Le, T., Sennino, B., Thurston, G., Kuo, C. J., Hu-Lowe, D., & McDonald, D. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00616.2005 · Cited by 374
VEGF as a Mediator of Tumor-Associated Immunodeficiency
Ohm, J. E., & Carbone, D. P. (2001) · Immunologic Research · doi:10.1385/ir:23:2-3:263 · Cited by 371
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
(2006) · New England Journal of Medicine · doi:10.1056/nejmc052954 · Cited by 365
Margolin, K., Gordon, M. S., Holmgren, E., Gaudreault, J., Novotny, W., Fyfe, G., Adelman, D., Stalter, S., & Breed, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.851 · Cited by 364
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
Kisucka, J., Butterfield, C. E., Duda, D. G., Eichenberger, S. C., Saffaripour, S., Ware, J., Ruggeri, Z. M., Jain, R. K., Folkman, J., & Wagner, D. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510412103 · Cited by 361
Dekker, R. J., Boon, R. A., Rondaij, M. G., Kragt, A., Volger, O. L., Elderkamp, Y. W., Meijers, J. C. M., Voorberg, J., Pannekoek, H., & Horrevoets, A. J. G. (2006) · Blood · doi:10.1182/blood-2005-08-3465 · Cited by 353
Bellamy, W. T., Richter, L., Sirjani, D., Roxas, C., Glinsmann-Gibson, B., Frutiger, Y., Grogan, T. M., & List, A. F. (2001) · Blood · doi:10.1182/blood.v97.5.1427 · Cited by 342
Awada, A., Hendlisz, A., Gil, T., Bartholomeus, S., Mano, M., de Valeriola, D., Strumberg, D., Brendel, E., Haase, C. G., Schwartz, B., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602584 · Cited by 339
Mechanisms of Hypertension Associated With BAY 43-9006
Veronese, M. L., Mosenkis, A., Flaherty, K. T., Gallagher, M., Stevenson, J. P., Townsend, R. R., & O'Dwyer, P. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0503 · Cited by 324
O'Farrell, A.-M., Foran, J. M., Fiedler, W., Serve, H. L., Paquette, R. L., Cooper, M. A., Yuen, H. A., Louie, S. G., Kim, H., Nicholas, S., et al. (2003) · PubMed · Cited by 310
Relationship between platelet count and bleeding risk in thrombocytopenic patients
SLICHTER, S. (2004) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2004.03.003 · Cited by 305
Katoh, O., Tauchi, H., Kawaishi, K., Kimura, A., & Satow, Y. (1995) · PubMed · Cited by 303
Polverino, A., Coxon, A., Starnes, C., Diaz, Z., DeMelfi, T., Wang, L., Bready, J., Estrada, J., Cattley, R., Kaufman, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4665 · Cited by 287
Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991-2001
Baker, S. D., Verweij, J., Rowinsky, E. K., Donehower, R. C., Schellens, J. H. M., Grochow, L. B., & Sparreboom, A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.24.1883 · Cited by 286
Kim, D. W., Jo, Y. S., Jung, H. S., Chung, H. K., Song, J. H., Park, K. C., Park, S. H., Hwang, J. H., Rha, S. Y., Kweon, G. R., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2845 · Cited by 279
Kuenen, B. C., Rosen, L. S., Smit, E. F., Parson, M., Levi, M. M., Ruijter, R., Huisman, H., Kedde, M. A., Noordhuis, P., van der Vijgh, W. J. F., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1657 · Cited by 279
Self-citationAugustin, H. G., Kozian, D. H., & Johnson, R. C. (1994) · BioEssays · doi:10.1002/bies.950161208 · Cited by 274
Zucker, S., Mirza, H., Conner, C. E., Lorenz, A. F., Drews, M. H., Bahou, W. F., & Jesty, J. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980302)75:5<780::aid-ijc19>3.0.co;2-a · Cited by 270
Eppler, S. M., Combs, D. L., Henry, T. D., Lopez, J. J., Ellis, S. G., Yi, J., Annex, B. H., McCluskey, E. R., & Zioncheck, T. F. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126179 · Cited by 266
Preservation of Vascular Integrity in Organs perfused in vitro with a Platelet-rich Medium
GIMBRONE, M. A., ASTER, R. H., COTRAN, R. S., CORKERY, J., JANDL, J. H., & FOLKMAN, J. (1969) · Nature · doi:10.1038/222033a0 · Cited by 257
Shoji, M., Hancock, W. W., Abé, K., Micko, C. J., Casper, K. A., Baine, R. M., Wilcox, J. N., Danave, I. R., Dillehay, D. L., Matthews, E., et al. (1998) · Europe PMC (PubMed Central) · Cited by 248
Eremina, V., Cui, S., Gerber, H., Ferrara, N., Haigh, J., Nagy, A., Ema, M., Rossant, J., Jothy, S., Miner, J. H., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080810 · Cited by 246
Ma, L., Elliott, S. N., Cirino, G., Buret, A., Ignarro, L. J., & Wallace, J. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111150798 · Cited by 244
Masuda, Y., Shimizu, A., Mori, T., Ishiwata, T., Kitamura, H., Ohashi, R., Ishizaki, M., Asano, G., Sugisaki, Y., & Yamanaka, N. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61731-2 · Cited by 234
Bergmeier, W., Piffath, C. L., Goerge, T., Cifuni, S. M., Ruggeri, Z. M., Ware, J., & Wagner, D. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608207103 · Cited by 233
Predicting benefit from anti-angiogenic agents in malignancy
Jubb, A. M., Oates, A. J., Holden, S., & Koeppen, H. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1946 · Cited by 228
Huang, J., Frischer, J. S., Serur, A., Kadenhe, A., Yokoi, A., McCrudden, K. W., New, T., O'Toole, K., Zabski, S., Rudge, J. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432908100 · Cited by 227
Vascular Endothelium as the Vulnerable Element in Tumours
Denekamp, J. (1984) · Acta Radiologica: Oncology · doi:10.3109/02841868409136015 · Cited by 222
Hong, C. C., Peterson, Q. P., Hong, J.-Y., & Peterson, R. T. (2006) · Current Biology · doi:10.1016/j.cub.2006.05.046 · Cited by 221
Scotland, R. S., Madhani, M., Chauhan, S., Moncada, S., Andresen, J., Nilsson, H., Hobbs, A. J., & Ahluwalia, A. (2005) · Circulation · doi:10.1161/01.cir.0000155238.70797.4e · Cited by 217
Podar, K., Tonon, G., Sattler, M., Tai, Y.-T., LeGouill, S., Yasui, H., Ishitsuka, K., Kumar, S., Kumar, R., Pandite, L. N., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609329103 · Cited by 216
Reinmuth, N., Liu, W., Jung, Y. D., Ahmad, S. A., Shaheen, R. M., Fan, F., Bucana, C. D., McMahon, G., Gallick, G. E., & Ellis, L. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0693fje · Cited by 214
Verheul, H. M. W., Jorna, A. S., Hoekman, K., Broxterman, H. J., Gebbink, M. F. B. G., & Pinedo, H. M. (2000) · Blood · doi:10.1182/blood.v96.13.4216 · Cited by 210
Self-citationGasparini, G., Longo, R., Fanelli, M., & Teicher, B. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.022 · Cited by 200
Angiogenic growth factors and hypertension
Sane, D. C., Anton, L., & Brosnihan, K. B. (2004) · Angiogenesis · doi:10.1007/s10456-004-2699-3 · Cited by 195
Karp, J. E., Gojo, I., Pili, R., Gocke, C. D., Greer, J., Guo, C., Qian, D., Morris, L., Tidwell, M., Chen, H., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0627 · Cited by 180
Mechanisms of Cancer-Induced Thrombosis in Cancer
Rickles, F. R. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093551 · Cited by 176
Expression of vascular endothelial growth factor protein in human renal cell carcinoma
Jacobsen, J., Grankvist, K., Rasmuson, T., Bergh, A., Landberg, G., & Ljungberg, B. (2004) · BJU International · doi:10.1111/j.1464-410x.2004.04605.x · Cited by 173
Gélinas, D. S., Bernatchez, P. N., Rollin, S., Bazan, N. G., & Sirois, M. G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704956 · Cited by 166
Imatinib mesylate causes hypopigmentation in the skin
Tsao, A. S., Kantarjian, H., Cortes, J., O'Brien, S., & Talpaz, M. (2003) · Cancer · doi:10.1002/cncr.11812 · Cited by 161
Strumberg, D., Awada, A. H., Hirte, H. W., Clark, J. W., Seeber, S., Piccart, P., Hofstra, E., Voliotis, D., Christensen, O., Brueckner, A., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.11.014 · Cited by 150
Kuenen, B. C., Levi, M. M., Meijers, J. C. M., Kakkar, A. K., van Hinsbergh, V. W. M., Kostense, P. J., Pinedo, H. M., & Hoekman, K. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000030186.66672.36 · Cited by 148
Self-citationKoomägi, R., & Volm, M. (1998) · International Journal of Cancer · Cited by 142
Lordick, F., Geinitz, H., Theisen, J., Sendler, A., & Sarbia, M. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.12.004 · Cited by 131
Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma
Wright, J. D., Hagemann, A. R., Rader, J. S., et al. (2006) · Cancer · doi:10.1002/cncr.21969 · Cited by 128
Angiogenesis Inhibitors and Hypertension: An Emerging Issue
Sica, D. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5740 · Cited by 127
KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF
Li, B., Ogasawara, A. K., Yang, R., Wei, W., He, G., Zioncheck, T. F., Bunting, S., de Vos, A. M., & Jin, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000018588.56950.7a · Cited by 121
Drevs, J., Zirrgiebel, U., Schmidt-Gersbach, C., Mross, K. B., Medinger, M., Lee, L., Pinheiro, J. C., Wood, J. M., Thomas, A., Unger, C., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi118 · Cited by 121
Sunitinib malate for the treatment of solid tumours: a review of current clinical data
Motzer, R. J., Hoosen, S., Bello, C. L., & Christensen, J. G. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.5.553 · Cited by 119
The functional role of blood platelet components in angiogenesis
Silvia, U., Fischer, S., Morgenstern, E., Hammes, H., Rhee, J.-S., Black, M., & Preissner, K. T. (2004) · Thrombosis and Haemostasis · doi:10.1160/th03-04-0213 · Cited by 118
Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP
Guan, F., Villegas, G., Teichman, J., Mundel, P. H., & Tufró, A. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00448.2005 · Cited by 116
McCarty, M. F., Wey, J. S., Stoeltzing, O., Liu, W., Fan, F., Bucana, C. D., Mansfield, P. F., Ryan, A. J., & Ellis, L. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1041.3.9 · Cited by 114
Saltz, L. B., Clarke, S. J., Díaz‐Rubio, E., Scheithauer, W., Figer, A., Wong, R. K. S., Koski, S. L., Lichinitser, M., Yang, T., & Cassidy, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4028 · Cited by 113
Normal endothelial cell function
Pearson, J. D. (2000) · Lupus · doi:10.1191/096120300678828299 · Cited by 111
The role of the coagulation system in tumour angiogenesis
Nash, G., Walsh, D., & Kakkar, A. K. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00518-6 · Cited by 108
Hara, A., Wada, T., Furuichi, K., Sakai, N., Kawachi, H., Shimizu, F., Shibuya, M., Matsushima, K., Yokoyama, H., Egashira, K., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000439 · Cited by 107
Reversible Posterior Leukoencephalopathy Syndrome Induced by RAF Kinase Inhibitor BAY 43-9006
Govindarajan, R., Adusumilli, J., Baxter, D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.4608 · Cited by 106
Bellamy, W. T. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90023-5 · Cited by 105
Mross, K. B., Steinbild, S., Baas, F., Gmehling, D., Radtke, M., Voliotis, D., Brendel, E., Christensen, O., & Unger, C. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.032 · Cited by 104
Phase II Study of the Antiangiogenic Agent SU5416 in Patients with Advanced Soft Tissue Sarcomas
Heymach, J. V., Desai, J., Manola, J. B., Davis, D. W., McConkey, D. J., Harmon, D. C., Ryan, D. P., Goss, G., Quigley, T., den Abbeele, A. D. V., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0157 · Cited by 97
Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function
Jf, W., Milosveski, V., Schramek, C., Fong, G. H., Becks, G. P., & Hill, D. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1570005 · Cited by 96
Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences
Broxterman, H. J., Lankelma, J., & Hoekman, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00026-8 · Cited by 91
Pawliński, R., Pedersen, B., Erlich, J., & Mackman, N. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-05-0309 · Cited by 89
Maximizing Ventricular Function With Multimodal Cell-Based Gene Therapy
Yau, T. M., Kim, C., Li, G., Zhang, Y., Weisel, R. D., & Li, R. (2005) · Circulation · doi:10.1161/circulationaha.104.525147 · Cited by 86
Cassidy, J., Clarke, S. J., Díaz‐Rubio, E., Scheithauer, W., Figer, A., Wong, R. P. W., Koski, S. L., Lichinitser, M., Yang, J. T., & Saltz, L. B. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.4030 · Cited by 77
Ma, L., Francia, G., Viloria‐Petit, A., Hicklin, D. J., du Manoir, J. M., Rak, J. W., & Kerbel, R. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3156 · Cited by 75
Large Amounts of Vascular Endothelial Growth Factor at the Site of Hemostatic Plug Formation In Vivo
Weltermann, A., Wolzt, M., Petersmann, K., Czerni, C., Graselli, U., Lechner, K., & Kyrle, P. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.7.1757 · Cited by 71
Non-Small Cell Lung Cancer and Antiangiogenic Therapy: What Can Be Expected of Bevacizumab?
Herbst, R. S., & Sandler, A. B. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_1-19 · Cited by 69
Gérard, A.-C., Many, M., Daumerie, C., Costagliola, S., Miot, F. E. L., DEVIJLDER, J., Colin, I. M., & Denef, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8278 · Cited by 58
Identification of functional VEGF receptors on human platelets
Selheim, F., Holmsen, H., & Vassbotn, F. S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02232-9 · Cited by 58
Goodlad, R. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl113 · Cited by 56
Capillary rarefaction and abnormal cardiovascular reactivity in hypertension
Ciuffetti, G., Schillaci, G., Innocente, S., Lombardini, R., Pasqualini, L., Notaristefano, S., & Mannarino, E. (2003) · Journal of Hypertension · doi:10.1097/00004872-200312000-00018 · Cited by 47
Inhibition of angiogenesis in cancer patients
Verheul, H. M. W., & Pinedo, H. M. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.2.403 · Cited by 24
Self-citationYang, C., Chu, K., & Yeh, W. (2003) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10074 · Cited by 18
Long-Term Treatment with Bevacizumab for Patients with Metastatic Colorectal Cancer: Case Report
Hurwitz, H. I., Honeycutt, W., Haley, S. T., & Favaro, J. (2006) · Clinical Colorectal Cancer · doi:10.3816/ccc.2006.n.023 · Cited by 16
Long-term response with sunitinib for metastatic renal cell carcinoma
Ronnen, E. A., Kondagunta, G. V., Ginsberg, M. S., et al. (2006) · Urology · doi:10.1016/j.urology.2006.03.042 · Cited by 9
Duan, W. R., Patyna, S. J., Kuhlmann, M. A., Li, S., & Blomme, E. A. G. (2006) · Journal of Investigative Surgery · doi:10.1080/08941930600778248 · Cited by 7
Cited by
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0281-3 · Cited by 765
Fernández, M., Semela, D., Bruix, J., Colle, I., Pinzani, M., & Bosch, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.011 · Cited by 600
Role and Therapeutic Potential of VEGF in the Nervous System
Ruiz de Almodovar, C., Lambrechts, D., Mazzone, M., & Carmeliet, P. (2009) · Physiological Reviews · doi:10.1152/physrev.00031.2008 · Cited by 448
Comprehensive characterization of the Published Kinase Inhibitor Set
Elkins, J. M., Fedele, V., Szklarz, M., Abdul Azeez, K. R., Salah, E., Mikolajczyk, J., Romanov, S., Sepetov, N., Huang, X.-P., Roth, B. L., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3374 · Cited by 323
Kazazi-Hyseni, F., Beijnen, J. H., & Schellens, J. H. M. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0317 · Cited by 291
Metadata
- Authors
- Verheul, H. M. W., & Pinedo, H. M.
- Venue
- Nature Reviews Cancer
- Published
- 2007-06
- Volume
- 7
- Issue
- 6
- Pages
- 475-485
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1970421475
- Cited by
- 503
- References
- 125
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.